Latest news

“The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance” Dr Gilles Courtemanche, BIOASTER Antimicrobials Program Head is co-author of a scientific publication “MMV688533, a preclinical candidate to cure malaria” @ScienceTM Science Translational Medicine 21 Jul 2021: Vol. 13, Issue 603, eabg6013  https://stm.sciencemag.org/content/13/603/eabg6013...

Zoom

BIOASTER in collaboration with Cochin Hospital and the REALISM project consortium (study of the pathophysiology of intensive care patients and on biomarkers), has just published...

The first Institute for technological innovation in applied microbiology

Violet
Technologies designed by BIOASTER
Jaune
Disrupting healthcare
Bleu
Technologies overview
Orange
Scientific & technology experts
Rouge
Projects, Partners & Publications